newsfilter
← Latest News
GlobeNewswire·

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

WALTHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2026, on Thursday, November